Health

Sham Innovation Santé is set to exit the oncology diagnostics test developer in an cash-and-stock acquisition expected to close later this year.

Stablix Therapeutics has launched with $63m in equity financing to commercialise research pioneered in Henry Colecraft’s laboratory at Columbia University.

Real estate platform developer raised $40m in a round led by Invesco Real Estate while Legend Capital contributed to a round for video shopping service Feiyu.Live.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Johnson & Johnson Innovation – JJDC has re-upped its commitment to the chronic conditions treatment provider having participated in a series C round valuing it at over $1bn post-money.

WuXi AppTec, Fosun, Sinopharm and Humanwell have all invested in the oncology treatment developer, which has filed to raise up to $100m.

SoftBank contributed to a $65m round for fresh produce marketplace Frubana while KDDI invested in food ordering service Menu at a $228m valuation.

The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.

Bayer and Fujifilm could exit the oncology therapy developer through an initial public offering with a $100m placeholder target.

Oriola sold part of its stake in telehealth platform developer Doktor.se through a $61.1m round while bicycle marketplace The Pro’s Closet bagged $40m.

Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.